Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition.
Cho
Leslie
L
Department of Cardiology, Loyola University Medical Center, Maywood, Illinois 60153, USA. lcho@lumc.edu <lcho@lumc.edu>
Chew
Derek P
DP
Moliterno
David J
DJ
Roffi
Marco
M
Ellis
Stephen G
SG
Franco
Irving
I
Bajzer
Christopher
C
Bhatt
Deepak L
DL
Dorosti
Khosrow
K
Simpfendorder
Conrad
C
Tuzcu
Murat
M
Yadav
Jay S
JS
Brener
Sorin
S
Raymond
Russell
R
Whitlow
Patrick
P
Topol
Eric J
EJ
Lincoff
A Michael
AM
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D019917:Blood Vessel Prosthesis Implantation; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006629:Hirudins / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D010446:Peptide Fragments / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D015607:Stents; D015996:Survival Rate
D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011994:Recombinant Proteins; C074619:bivalirudin